Drreddys Laboratories | RDY - Ebitda


Drreddys Laboratories reported INR8.63B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 3.7M 14.78M Mar/2026
Bayer EUR 4.45B 2.49B Mar/2026
Canopy Growth CAD -137M 134.13M Mar/2026
Cipla INR 9.55B 3B Mar/2026
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Drreddys Laboratories INR 8.63B 12.96B Mar/2026
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Novartis USD 5.3B 530M Mar/2026
Pacira USD 40.24M 1.53M Mar/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Richter Gedeon HUF 83.47B 692M Mar/2026
Sun Pharmaceuticals INR 39.54B 9.94B Mar/2026
Supernus Pharmaceuticals USD 29.23M 19.27M Mar/2026
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026